Nantahala reports 4.72% Verastem stake
Nantahala Capital Management, LLC and its principals report a significant but sub‑5% stake in Verastem, Inc. They disclose beneficial ownership of 3,795,473 shares of Verastem common stock, representing 4.72% of the outstanding class as of December 31, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nantahala Capital Management, LLC and its principals report a significant but sub‑5% stake in Verastem, Inc. They disclose beneficial ownership of 3,795,473 shares of Verastem common stock, representing 4.72% of the outstanding class as of December 31, 2025.
The filing states that Nantahala, Wilmot B. Harkey, and Daniel Mack share voting and dispositive power over these shares and have no sole voting or dispositive authority. They certify that the securities were acquired and are held in the ordinary course of business, not to change or influence control of Verastem.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Verastem (VSTM) does Nantahala Capital report in this Schedule 13G/A?
Who are the reporting persons in the Verastem (VSTM) Schedule 13G/A filing?
What does the Verastem (VSTM) Schedule 13G/A say about intent to influence control?
On what date is the Verastem (VSTM) ownership information measured in this filing?
Does the Verastem (VSTM) Schedule 13G/A indicate ownership of more than 5% of the stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.